Mini-dose methotrexate combined with methylprednisolone as a first-line treatment for acute graft-versus-host disease: A phase 2 trial.
Zhengli XuXiaodong MoYuan KongQi WenTingting HanMeng LyuLanping XuYingjun ChangXiaohui ZhangXiaojun HuangYu WangPublished in: Journal of translational internal medicine (2023)
The current study suggests that mini-dose MTX combined with standard-dose MP could potentially become a novel first-line therapy for patients with aGvHD.